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Abstract:  Introduction: Aerosol-
generating procedures (AGPs) put 
the dental health care professionals 
(DHCPs) at a greater risk for acquiring 
severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) infection. 
In late June 2020, the Centers for 
Disease Control and Prevention 
advised elective dental procedures 
provision to asymptomatic patients 
while mandating strict infection 
control protocol and suggested the 
use of preprocedural testing as an 
adjunct. A cost-effective method for 
mass preprocedural testing is pool 
testing, which has specificity and 
sensitivity similar to polymerase chain 
reaction. This article aims to assess the 
outcomes and utility of incorporating 
preprocedural testing protocol for 
SARS-CoV-2 in dental clinics before 
providing AGPs.
Method: The patients who were 
recommended AGPs where rubber 
dam placement was not possible were 
advised to undergo preprocedural 
testing for SARS-CoV-2. Pool testing 
strategy was employed, and patients 
were asked to get tested 48 h before the 
day of the procedure.
Results: Out of a total of 1,000 
patients, who presented from June 
2020 to late July 2020, 464 were 
recommended dental procedures. 
In 194 of 464, AGPs could not be 
performed under rubber dam isolation; 
therefore, the patients were advised to 
get a preprocedural pool test. In total, 
111 patients deferred the procedure 
and testing. Out of 83 who got tested, 
7 were positive for SARS-CoV-2, 5 of 
whom were tested in early June 2020 
and 2 in late July 2020.
Conclusion: Pool testing within 
its limitations can be a useful 
preprocedure test in asymptomatic 
low-risk patients for AGP in dentistry, 
especially when the disease prevalence 
is low or moderate (<10%). It has the 
potential of reducing testing costs 
significantly while conserving reagent 
and other resources. Preprocedure 
testing, however, also gives rise to 
certain ethical concerns that also need 
to be addressed.
Knowledge Transfer Statement: 
The results of this study can be used 
by clinicians when deciding which 
preprocedure testing approach 
they wish to use when performing 
aerosol-generating procedures 
in asymptomatic patients with 
consideration of cost sensitivity and 
specificity values.
Keywords: coronavirus infections/
diagnosis, specimen handling, 
economics, clinical laboratory 
techniques, pandemics, polymerase 
chain reaction
Introduction
Severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) was declared 
a global pandemic in March 2020, 
and since then, it has claimed millions 
of lives and trillions of dollars. Many 
countries had to impose lockdown for 
approximately 7 wk to slow the virus 
spread, but this negatively affected the 
economy in all sectors, especially the 
health care sector (Emanuel et al. 2020).
The most commonly known SARS-
CoV-2 transmission route is through 
inhalation of respiratory droplets or 
aerosols from infected individuals ( Jamal 
et al. 2020). In the dental clinic, aerosols 
are generated during dental procedures 
as a result of water irrigation for cooling 
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of the dental handpieces and ultrasonic 
devices (Epstein et al. 2020). Furthermore, 
high viral loads have been found in 
the saliva of both symptomatic and 
asymptomatic infected patients. Thus, the 
dual effect of aerosol generation along 
with saliva and the fact that dental work 
requires close proximity and prolonged 
contact time leaves dental health care 
providers (DHCPs) particularly vulnerable 
to contract coronavirus disease 2019 
(COVID-19) infection (Jamal et al. 2020). 
This led to confinement of dental work to 
emergency management only to reduce 
the risk of cross-infection, consequently 
leading to grave monetary losses in the 
dental practices (Schwendicke et al. 
2020).
Pakistan received positive confirmation 
of SARS-CoV-2 cases in February 
2020, which eventually led to strict 
lockdown enforcement (Tariq et al. 
2020). However, during late May 2020, 
many countries, including Pakistan, 
eased lockdown restrictions, allowing 
the return of workflow to normalcy. This 
facilitated elective treatment in dentistry 
per Centers for Disease Control and 
Prevention (CDC) guidelines, which 
further suggested that “facilities can 
consider implementing preadmission 




This preprocedural testing is 
important because an asymptomatic/
presymptomatic patient poses the 
greatest risk of contagion, especially 
while providing aerosol-generating 
procedures (AGPs) (Lauer et al. 2020). 
An ideal preprocedural test should be 
cost-effective, highly sensitive, and easy 
to perform, and it should generate rapid 
results. For SARS-CoV-2 diagnosis, real-
time reverse transcription polymerase 
chain reaction test (RT-PCR) is the gold-
standard test that is performed using 
respiratory samples. However, RT-PCR 
testing is expensive, time-consuming, and 
requires specialized infrastructure (Wu et 
al. 2020). A single RT-PCR test may cost 
approximately $41 in Pakistan and the 
United States (Mahony et al. 2004). Other 
alternative methods for preprocedure 
testing are antigen and antibody tests, 
which, although rapid, may suffer from 
suboptimal sensitivity (36.4%) (Pan 
et al. 2020). Furthermore, antibodies 
may take up to 12 to 14 d to develop; 
hence, the efficacy of the antibody test is 
reduced in the acute phase of infection 
when the patient is asymptomatic/
presymptomatic and therefore has 
limited use as a preprocedural test in 
asymptomatic patients (Zhao et al. 2020). 
In contrast, the latest literature on pool 
sampling for COVID-19 screening has 
shown promising results with sensitivity 
values of 91%, which is close to RT-PCR 
(Mutesa et al. 2020). Furthermore, the 
pool testing strategy offers the advantage 
of reduced operational costs in certain 
circumstances by up to 20-folds while 
preserving reagents as well as specialized 
human resources (Mutesa et al. 2020). 
However, pool testing inherits all the 
aforementioned disadvantages of being 
an RT-PCR–based test.
Due to the low costs it offers to 
the patients while maintaining high 
sensitivity, it was decided that all those 
patients requiring surgical procedures 
under general anesthesia and AGPs 
without a rubber dam in dentistry would 
be required to undergo preprocedure 
pool testing.
It seems unlikely that an infected 
symptomatic individual would seek 
elective dental care, and therefore, 
the biggest challenge our profession 
faces is the risk of getting infected 
by asymptomatic spreaders. With the 
COVID-19 cases perpetually increasing, it 
is imperative in order for our profession 
to thrive that we come up with neoteric 
solutions to counter this hazard. In this 
communication, we have highlighted the 
concept of the pool testing, which was 
strategically used as a preprocedural test 
for patients requiring elective AGPs.
Method
The dental clinic at our tertiary 
care hospital started elective dental 
treatment on May 28, 2020. Non- AGPs 
were carried out if the patient was 
asymptomatic after initial screening, 
and AGPs were done under rubber dam 
isolation. This was allowed because 
it has been demonstrated that rubber 
dam isolation can decrease aerosol 
generation by up to 70% within a 3-foot 
radius ( Jamal et al. 2020). However, 
preprocedural testing was mandatory 
in procedures such as crown cutting, 
endodontic surgery, surgical extractions, 
and other AGPs in which rubber dam 
isolation was not feasible (Umer and 
Motiwala 2020).
The patients were counseled about the 
usefulness of preprocedure testing and 
asked to get the test done 48 h before 
the procedure. After the test was done, 
patients were asked to self-isolate for  
2 d. To ensure cost-effective and reliable 
preprocedural testing, we employed the 
“pool testing” strategy.
To get tested, the patient was given 
an option of an appointment at the 
centralized hospital testing site or, if they 
had privacy or any other concerns, they 
could opt for at-home testing service 
for an additional service fee. Pooling 
samples were compiled on a first come, 
first serve basis in a central biosafety 
level III laboratory. The pool size was 
internally validated according to US Food 
and Drug Administration (FDA) policy  
for the COVID-19 test (https://www 
.fda.gov/media/135659/download), and 
each pool consisted of 6 samples (6:1 
ratio) collected as nasopharyngeal swabs 
(Hogan et al. 2020).
These samples were stored at 4°C 
before processing for virus isolation 
and nucleic acid detection purposes. 
Furthermore, each specimen went 
through a process of batch organization 
and was given dual identification 
and a barcode through an electronic 
lab tracking system. They were also 
manually registered in the logbook so 
that samples were not mixed.
The test was run on a Cobas SARS-
CoV-2, based on fully automated sample 
preparation (nucleic acid extraction 
and purification), followed by PCR 
amplification and detection. Selective 
amplification of target nucleic acid from 
the samples was achieved by the use 
of target-specific forward and reverse 
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primers for ORF1 a/b nonstructural 
region that is unique to SARS-CoV-2. 
In addition, a conserved region in the 
structural protein envelope E-gene was 
chosen for pan-Sarbecovirus detection. 
The pan-Sarbecovirus detection sets also 
detect the SARS-CoV-2 virus. Finally, the 
sample was stored for another 48 h after 
reporting before being discarded.
According to the Dorfman algorithm, 
if the pool tests are negative, then all 
individuals in that pool have been 
efficiently tested with a single test, 
allowing conservative usage of reagents 
and finances, with results posted in 
24 h (Wacharapluesadee et al. 2020). 
However, in the case of positive pool 
tests, at least 1 person in the group 
is tested positive for the disease, and 
each sample from the pool needs an 
additional test using RT-PCR. This added 
a delay of 24 h (Wacharapluesadee et al. 
2020), and therefore all the patients were 
scheduled for dental procedures after  
48 h from the date of the test (Figure).
Results
From May 28, 2020, to July 20, 2020, 
a total of 1,000 patients had visited the 
dental clinics. Out of these, 536 patients 
received consultation only. Procedures 
were recommended for 464 patients, 
which included non-AGPs, AGPs under 
rubber dam isolation, and AGPs after 
preprocedural testing (Table). Out 
of 464 procedures, 270 patients had 
undergone treatment without the need 
for preprocedural testing (AGPs under 
rubber dam isolation and non-AGPs), 
whereas 194 (out of 464) patients were 
advised AGPs in which rubber dam 
placement was not feasible, and hence 
preprocedural testing was recommended. 
Out of these 194 patients, 111 patients 
chose not to get preprocedural testing, 
and the remaining 83 got testing done, 
out of whom 76 patients tested negative 
and 7 tested positive for SARS-CoV-2.
The rate of infection varied in the early 
and late halves of June 2020. Between 
May 28 and June 15, 2020, of the 40 
patients advised preprocedure testing, 
14 patients opted not to get tested 
and 26 got tested. Consequently, 21 
tested negative and 5 tested positive for 
SARS-CoV-2.
From June 16 to July 20, 2020, the 
influx of patients had increased, and a 
total of 154 patients were recommended 
dental procedures, including AGPs and 
non-AGPs. Out of these, a total of 57 
patients got tested; 55 were negative 
and only 2 tested positive. The overall 
positivity rate of the tests done during 
this period was 6.7%.
Discussion
The concept of “pool testing” was 
introduced by Robert Dorfman in 1943 
and has been used since for screening 
infectious diseases (e.g., influenza virus, 
hepatitis B virus, hepatitis C virus, and 
human immunodeficiency virus [HIV]) 
(Hogan et al. 2020). It is a form of 
Figure. Workflow for preprocedure testing. *AGPs (aerosol-generating procedures) include crown cutting, surgical extraction, and 
scaling and polishing and have to be performed without a rubber dam.
Patients from all departments of 
the hospital are referred to one 
site for COVID-19 testing
Low risk asymptomatic patients 
undergoing AGPs* require pre-
procedural testing
Nasopharyngeal 
swabs are taken for 
COVID-19 testing
6 samples are pooled together for 
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group testing, which nowadays is used 
as a screening tool to identify low-risk 
or asymptomatic SARS-CoV-2 patients 
(Hogan et al. 2020).
The aim of this policy development 
at the dental clinic of our university 
hospital was to devise a strategy to 
ensure maximum care to the patients 
while conserving personal protective 
equipment (PPE) and minimizing the 
infection rate among DHCPs who are 
directly involved in providing patient 
care. To the best of our knowledge, 
this strategy has previously been 
researched for population screening 
and epidemiological surveys but not 
as a preprocedural protocol (Hogan 
et al. 2020). According to our findings, 
preprocedural testing allowed us to 
provide safe elective dental treatment 
to our patients during the pandemic. 
We were also successful in curtailing 
transmission of the infection to dentists 
and auxiliary staff, especially in June 
2020, when the national infection rate 
was at its peak. This had a considerable 
impact on the prevention of infection 
in the dental department at Aga 
Khan University Hospital, where the 
nosocomial infection rate was maintained 
to zero (Umer 2020b).
“Pool testing” also addressed patients’ 
financial concerns, as the pool testing 
method provides sensitivity similar to the 
RT-PCR test, with a total cost of $17 at 
our testing site. The cost of a single pool 
test is approximately one-third of the total 
cost for the RT-PCR test at our center. This 
cost can further decrease by 20-fold with 
a larger pool size (Mutesa et al. 2020). 
Furthermore, this strategy conserves 
reagents and the workforce required for 
testing without overloading the system 
in a resource-restrained environment 
(Wacharapluesadee et al. 2020).
Elective dental treatment was deferred 
in case the patient tested positive 
for SARS-CoV-2. These patients are 
further asked to meet with SARS-CoV-2 
monitoring staff, who provided them 
with basic knowledge, understanding, 
and particulars of care for the infected 
individuals. The hospital also had the 
provision of a negative pressure room 
equipped with a portable dental unit 
should there be a need to treat a COVID-
19–positive patient for emergency dental 
work (Umer 2020a).
The patients who opted not to get 
tested were contacted at a later date over 
the phone and were asked reasons for 
not getting tested. The most common 
reason stated was the fear of getting 
a positive test result. This behavior is 
commonly known as willful ignorance 
or strategic ignorance, in which patients 
avoid medical diagnosis for the fear of 
social costs (14-d isolation, stigma, and 
opportunity cost), which outweigh any 
benefits of testing. This behavior is also 
seen in patients with other diseases like 
HIV or breast cancer (Thunström et al. 
2020).
The major limitation of employing pool 
testing is that it is a type of PCR test with 
similar disadvantages, such as it is time-
consuming and requires a high level 
of PPE and skilled staff to cater to the 
amplified risk of infection that comes 
along with collecting the nasopharyngeal 
samples (Pan et al. 2020).
Another limitation of our strategy is 
that the sensitivity and specificity of pool 
testing were not scrutinized as a head-to-
head comparison against gold-standard 
RT-PCR, as we do not know if sample 
pooling causes a dilution effect that may 
negatively affect the diagnostic validity 
of the test. To investigate this uncertainty, 
further diagnostic validity studies are 
required comparing RT-PCR with pool 
testing. Only 1 study is known to us that 
conducted a head-to-head comparison and 
did not find any difference between the 
pool test and RT-PCR in terms of sensitivity 
values, but the study was underpowered 
(Wacharapluesadee et al. 2020).
This protocol also raises a few ethical 
concerns as a false-negative result may 
subject the DHCPs to a false sense of 
security and an increased chance of 
exposure. In case of a false positive, the 
Table.
Summary of the AGPs, Non-AGPs, and Preprocedural Testing until July 20, 2020.
Characteristic
From May 28 to 
June 15, 2020
From June 16 
to July 20, 2020 Total No.
Patients who received consultation only 187 349 536
Procedures recommended 198 266 464
Patients provided non-AGPs and AGPs (no pretestinga) 108 162 270
Patients who were advised pretestinga 40 154 194
Patients who got tested and were provided AGPs 26 57 83
Patients who tested positive for SARS-CoV-2 (managed as per CDC guidelines) 5 2 7
Infection rate at AKUH, % 19.2 3.5 6.7
AGP, aerosol-generating procedure; AKUH, Aga Khan University Hospital; CDC, Centers for Disease Control and Prevention; SARS-CoV-2, severe acute respiratory 
syndrome coronavirus 2.
aPretesting of sample pooling was advised and tracked.
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patient may require further unneeded 
testing and/or may need to undergo self-
isolation and anxiety.
In our strategy, false negatives were 
considered true negatives as we did not 
subject our samples to further testing 
knowing that a false-negative rate of 
RT-PCR may range from 2% to 28% 
(sensitivity of 71%–98%). Therefore, 
it would be fair to assume that pool 
testing would also have a similar false-
negative rate, if not worse, and we 
recommend that even with negative pool 
test results, the DHCPs should follow 
appropriate PPE protocol (Umer et al. 
2020). However, we did have a default 
mechanism to check for false positives in 
which a pool with a positive result was 
rechecked with an individual RT-PCR. 
Considering that an RT-PCR has high 
specificity, it would be fair to assume 
that our positive pool test was a true 
positive (Watson et al. 2020).
Preprocedural pool testing strategy 
works best when the disease prevalence 
is low or moderate and the number of 
samples in the pool is determined by 
the disease prevalence; it might not be a 
useful protocol when disease prevalence 
is high (Wacharapluesadee et al. 2020). 
This is because low disease prevalence 
allows batching a larger pool size. As the 
prevalence increases, the positivity rate 
within the pool also increases, and thus 
the cost-saving benefit of pooling may be 
negated as the positive pool batches will 
be required to be retested. Therefore, 
the CDC recommends that laboratories 
should monitor disease prevalence 
according to their positivity rate over 
the previous 7 to 10 d and accordingly 
adjust pool sizes (https://www.cdc.gov/
coronavirus/2019-ncov/lab/pooling-
procedures.html).
According to a study published in the 
American Journal of Clinical Pathology, 
pool testing can be a useful and cost-
saving strategy as long as the incidence 
of SARS-CoV-2 infection remains below 
10%, and in our study, the positivity rate 
was 6.7% (Abdalhamid et al. 2020).
A further limitation of our study is that 
we know that COVID-19 infection may 
cause prolonged RNA shedding even 
when the patients are not infectious 
anymore. We did not account for any 
misclassification of our cases, who could 
have been postsymptomatic (Xu et al. 
2020).
An ethical implication of the 
preprocedure COVID-19 test is if a 
patient tests positive, how will the 
individual privacy be maintained? Of 
course, the dental team prescribing 
the test needs to be prompted by a 
positive test outcome so that the planned 
procedure can be deferred to a later 
date. At our institution, by law, we 
were obliged to share this information 
with the government, because to 
mitigate the spread of COVID-19, an 
early response was critical. Right now, 
such a response may be justified as we 
are trying to contain this pandemic. 
However, in the long run, it can give 
rise to complex individual privacy 
issues; hence, the legislature will be 
required to use aggregate data rather 
than individual data so that they are 
not misused. Meanwhile, at a practice 
level, we recommend that best practice 
according to local laws be identified 
and maintained for responsible use of 
such information. In our institution, for 
example, personnel assigned to inform 
and follow up positive patients were 
public health experts allocated by the 
local government and were legally 
bound to government data protection 
regulations.
Another ethical question that may arise 
is, if the patient refuses preprocedural 
testing, can the DHCPs refuse to 
do AGPs, especially if it is a dental 
emergency? Is it as simple as saying “no 
mask, no service”? This concern has not 
been answered, and when we joined 
this profession, we accepted a certain 
degree of risk associated with the trade. 
Therefore, refusing treatment to patients 
who opt not to get tested is an idea 
that may or may not get support from 
bioethics experts.
Conclusion
Pool testing within its limitations 
can be a useful preprocedure test in 
asymptomatic low-risk patients for 
AGPs in dentistry, especially when the 
disease prevalence is low or moderate 
(<10%). It has the potential of reducing 
testing costs significantly while 
conserving reagent and other resources. 
Preprocedure testing, however, also gives 
rise to certain ethical concerns that also 
need to be addressed.
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